ELF e.l.f. Beauty, Inc.
Perfumes, Cosmetics & Other Toilet Preparations · NYSE · SEC CIK 1600033 · Fiscal year ends 03/31
Financial factors as of 2026-09-30 (2027Q2), TTM = sum of the last four quarters
Growth
TTM revenue YoY39.9%
TTM net income YoY5.9%
TTM EPS YoY2.1%
Revenue 3-yr CAGR36.3%
Net income 3-yr CAGR-10.7%
Margins
Gross margin74.4%
Operating margin8.9%
Net margin4.5%
FCF margin14.2%
EBITDA margin13.9%
Returns
ROE7.3%
ROA3.5%
ROIC (approx.)6.5%
Asset turnover0.79x
Leverage & solvency
Liabilities / assets52.3%
Debt / equity0.67x
Current ratio2.57x
Interest coverage—
Cash quality & payout
Operating cash flow / net income3.33x
Accruals ratio-8.2%
Payout ratio—
Capex / revenue0.6%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20262026-03-31 | FY20252025-03-31 |
|---|---|---|
| Income statement | ||
| Revenue | $1.64B | $1.31B |
| Cost of revenue | $479.12M | $377.83M |
| Gross profit | $1.16B | $935.69M |
| SG&A expense | $1.03B | $777.66M |
| Operating income | $73.63M | $158.03M |
| Pretax income | $40.46M | $145.50M |
| Income tax | $14.14M | $33.41M |
| Net income | $26.32M | $112.09M |
| EBITDA | $152.99M | $202.14M |
| EPS (basic) | 0.45 | 1.99 |
| EPS (diluted) | 0.44 | 1.92 |
| Weighted avg. shares (diluted) | 59.35M | 58.35M |
| Balance sheet | ||
| Cash & equivalents | $289.69M | $148.69M |
| Receivables | $174.64M | $126.01M |
| Inventory | $220.25M | $187.17M |
| Current assets | $789.37M | $540.56M |
| PP&E, net | $41.50M | $28.79M |
| Goodwill | $853.48M | $340.58M |
| Intangibles | $553.11M | $207.70M |
| Total assets | $2.39B | $1.25B |
| Current liabilities | $336.16M | $177.06M |
| Short-term debt | $30.00M | $0 |
| Long-term debt | $809.35M | $256.68M |
| Total debt | $839.35M | $256.68M |
| Total liabilities | $1.26B | $487.32M |
| Shareholders' equity | $1.13B | $760.86M |
| Net debt | $549.66M | $107.98M |
| Shares outstanding | 59.09M | 55.73M |
| Cash flow statement | ||
| Operating cash flow | $212.51M | $133.84M |
| Capital expenditure | $22.45M | $18.52M |
| Free cash flow | $190.06M | $115.32M |
| Investing cash flow | -$605.25M | -$19.10M |
| Financing cash flow | $533.92M | -$74.45M |
| Depreciation & amortization | $79.36M | $44.12M |
| Stock-based compensation | $86.92M | $71.79M |
| Share buybacks | $49.99M | $67.06M |
Free plan shows the latest 2 periods; Pro shows all 11 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.